(Q24242865)

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Chlorambucil dosage in frequently relapsingnephrotic syndrome: A controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Controlled trial of azathioprine in treatment of steroid-responsive nephrotic syndrome of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Long-term results of two unconventional agents in steroid-dependent nephrotic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Chlorambucil treatment of frequently relapsing nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Eight and 12 week courses of cyclophosphamide in nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Levamisole in steroid-sensitive nephrotic syndrome of childhood: the lost paradise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Concomitant administration of cyclosporine and ketoconazole in idiopathic nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Therapeutic effect of chai-ling-tang (sairei-to) on the steroid-dependent nephrotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Cyclophosphamide in the treatment of focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

The treatment of relapsing primary nephrotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

An evidence based approach to individualising treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Long-term outcome of primary nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Cyclosporin in the treatment of idiopathic nephrotic syndrome in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Side effects of levamisole in children with nephrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Randomized versus historical controls for clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Controlled trial of disodium cromoglycate in prevention of relapse of steroid-responsive nephrotic syndrome of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Non-corticosteroid treatment for nephrotic syndrome in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Non-corticosteroid treatment for nephrotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

Intravenous immunoglobulin in minimal change nephrotic syndrome: a crossover trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

164 children with nephrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

Sterility and testicular atrophy related to cyclophosphamide therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

Cyclophosphamide and the pubertal testis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

Is tacrolimus for childhood steroid-dependent nephrotic syndrome better than ciclosporin A?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

Comparison of different regimens of prednisone therapy in frequently relapsing nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

Consensus statement on management and audit potential for steroid responsive nephrotic syndrome. Report of a Workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

Unconjugated hyperbilirubinemia due to ciclosporin administration in children with nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

Evaluation of alternate-day steroid therapy for nephrotic syndrome in childhood by cross-over study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002290.PUB3

7 January 2021

10.1002/14651858.CD002290.PUB3

Identifiers

DOI

0 references

Fatcat ID

release_7kfavfbgcrhkdov6rup6n2pgnq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7kfavfbgcrhkdov6rup6n2pgnq

24 November 2022